Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia.

MLA

Even, C., et al. “Actinomycin D, Cisplatin, and Etoposide Regimen Is Associated with Almost Universal Cure in Patients with High-Risk Gestational Trophoblastic Neoplasia.” European Journal of Cancer (Oxford, England : 1990), vol. 50, no. 12, Aug. 2014, pp. 2082–89. EBSCOhost, https://doi.org/10.1016/j.ejca.2014.05.002.

APA

Even, C., Pautier, P., Duvillard, P., Floquet, A., Kerbrat, P., Troalen, F., Rey, A., Balleyguier, C., Tazi, Y., Leary, A., Augereau, P., Morice, P., Droz, J.-P., Fizazi, K., & Lhommé, C. (2014). Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia. European Journal of Cancer (Oxford, England : 1990), 50(12), 2082–2089. https://doi.org/10.1016/j.ejca.2014.05.002

Chicago

Even, C, P Pautier, P Duvillard, A Floquet, P Kerbrat, F Troalen, A Rey, et al. 2014. “Actinomycin D, Cisplatin, and Etoposide Regimen Is Associated with Almost Universal Cure in Patients with High-Risk Gestational Trophoblastic Neoplasia.” European Journal of Cancer (Oxford, England : 1990) 50 (12): 2082–89. doi:10.1016/j.ejca.2014.05.002.